Karen Flynn

Karen Flynn serves on the Board of Directors for Germfree and Sotera Health Company, contributing to aseptic processing and sterilization solutions within the healthcare industry. Additionally, Karen is a board member at Quanterix, focusing on precision instruments and assays. Previously, Karen held multiple leadership roles at Catalent Pharma Solutions, including President of Biomodalities and Biologics, as well as Chief Commercial Officer, and was also Chief Commercial Officer at West Pharmaceutical Services. With a strong background in global accounts at both Catalent Pharma Solutions and Cardinal Health, Karen's educational credentials include an MS in Engineering/Business from the University of Pennsylvania, an MS in Business Administration from Boston University, and a BS in Pre-Professional Studies from the University of Notre Dame.